Today, the National Institute for Health and Care Excellence (NICE) have given approval for the life-changing cystic fibrosis modulator drugs – Kaftrio, Symkevi and Orkambi - to be made available on the NHS in England. This follows many years of campaigning by Cystic Fibrosis Trust and people right across the CF community. This is a really significant moment as it offers certainty and hope to thousands of people affected by CF, a life-long, life-limiting condition without a cure. Head to our web

National Institute of Health and Care Excellence (NICE) have recommended risankizumab as a treatment option for some people with ulcerative colitis. Find out more by clicking the link below: https://crohnsandcolitis.org.uk/news-stories/news-items/nice-issues-final-guidance-recommending-risankizumab-for-ulcerative-colitis Image description: On a graphic containing images of various medications on a light blue background, the text reads in purple: 'Risankizumab is now a recommended treatment optio